Evaluation of the efficiency of chemical cartridges for respiratory protection against SARS-CoV-2

被引:1
|
作者
Paiva, Jose D. [1 ]
Neto, Paulo C. [1 ]
机构
[1] Inst Fed Pernambuco, Dept Res & Extens, BR-50750320 Abreu E Lima, PE, Brazil
来源
COGENT ENGINEERING | 2022年 / 9卷 / 01期
关键词
COVID-19; respirators; risk control; PPE; aerodispersoids;
D O I
10.1080/23311916.2022.2049484
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The shortage of PFF2, N95, KN95, and FFP2 respirators in the COVID-19 pandemic required that alternative respiratory protection measures be adopted to reduce the number of cases of the disease. Given this scenario, with the purpose of proving that chemical cartridges offer some degree of protection against aerodispersoids, among these those of biological origin, such as SARS-CoV-2, the filtering efficiency of chemical cartridges was evaluated. The evaluation of the filtering efficiency of cartridges was performed using the air filter test method, which uses micrometric air particles for the penetration test. The research proved that chemical cartridges, in general, have an average efficiency above 85% for respiratory protection against aerodispersoids. The multigas cartridge and organic vapor/acid gas cartridge had an average filtration efficiency of 91%. Chemical cartridges associated with facial or semi-facial respirators can become powerful resources for respiratory protection for people exposed to the virus, when the use of PFF2 or equivalent respirators is not possible.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
    Hsieh, Ching-Lin
    Leist, Sarah R.
    Miller, Emily Happy
    Zhou, Ling
    Powers, John M.
    Tse, Alexandra L.
    Wang, Albert
    West, Ande
    Zweigart, Mark R.
    Schisler, Jonathan C.
    Jangra, Rohit K.
    Chandran, Kartik
    Baric, Ralph S.
    Mclellan, Jason S.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] Regarding: Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality
    Song, Shan
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (01) : 121 - 122
  • [43] SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet's owners and with protection against subsequent SARS-CoV-2 infection?
    Murphy, Hannah
    Sanchez, Shania
    Ahmed, Shamim
    Rahman, Md. Mizanur
    Di, Da
    Dileepan, Mythili
    Heinrich, Daniel
    Liang, Yuying
    Ly, Hinh
    VIRULENCE, 2022, 13 (01) : 1216 - 1220
  • [44] Laboratory study of physical barrier efficiency for worker protection against SARS-CoV-2 while standing or sitting
    Bartels, Jacob
    Estill, Cheryl Fairfield
    Chen, I-Chen
    Neu, Dylan
    AEROSOL SCIENCE AND TECHNOLOGY, 2022, 56 (03) : 295 - 303
  • [45] Respiratory mucosal immunity against SARS-CoV-2 after vaccination and infection
    Tang, Jinyi
    Chaudhuri, Arka
    Qu, Panke
    Wu, Yue
    Wavell, Kristin
    Spano, Marthajoy
    Taylor, Justin
    Liu, Shan-lu
    Teague, William
    Sun, Jie
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [46] Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques
    McMahan, Katherine
    Wegmann, Frank
    Aid, Malika
    Sciacca, Michaela
    Liu, Jinyan
    Hachmann, Nicole P.
    Miller, Jessica
    Jacob-Dolan, Catherine
    Powers, Olivia
    Hope, David
    Wu, Cindy
    Pereira, Juliana
    Murdza, Tetyana
    Mazurek, Camille R.
    Hoyt, Amelia
    Boon, Adrianus C. M.
    Davis-Gardner, Meredith
    Suthar, Mehul S.
    Martinot, Amanda J.
    Boursiquot, Mona
    Cook, Anthony
    Pessaint, Laurent
    Lewis, Mark G.
    Andersen, Hanne
    Tolboom, Jeroen
    Serroyen, Jan
    Solforosi, Laura
    Costes, Lea M. M.
    Zahn, Roland C.
    Barouch, Dan H.
    NATURE, 2024, 626 (7998) : 385 - 391
  • [47] Duration of immune protection of SARS-CoV-2 natural infection against reinfection
    Chemaitelly, Hiam
    Nagelkerke, Nico
    Ayoub, Houssein H.
    Coyle, Peter
    Tang, Patrick
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Hasan, Mohammad R.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al-Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    JOURNAL OF TRAVEL MEDICINE, 2022, 29 (08)
  • [48] Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
    Altarawneh, Heba N.
    Chemaitelly, Hiam
    Hasan, Mohammad R.
    Ayoub, Houssein H.
    Qassim, Suelen
    AlMukdad, Sawsan
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Benslimane, Fatiha M.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Tang, Patrick
    Abu-Raddad, Laith J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13): : 1288 - 1290
  • [49] Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
    Pallett, Scott J. C.
    Heskin, Joseph
    Groppelli, Elisabetta
    Mazzella, Andrea
    Moore, Luke S. P.
    LANCET MICROBE, 2022, 3 (03): : E167 - E167
  • [50] Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
    Hanrath, Aidan T.
    Payne, Brendan A. I.
    Duncan, Christopher J. A.
    JOURNAL OF INFECTION, 2021, 82 (04) : E29 - E30